Cyril Foa

835 total citations
31 papers, 457 citations indexed

About

Cyril Foa is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Cyril Foa has authored 31 papers receiving a total of 457 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 17 papers in Pulmonary and Respiratory Medicine and 6 papers in Cancer Research. Recurrent topics in Cyril Foa's work include Cancer Treatment and Pharmacology (10 papers), Prostate Cancer Treatment and Research (7 papers) and Sarcoma Diagnosis and Treatment (4 papers). Cyril Foa is often cited by papers focused on Cancer Treatment and Pharmacology (10 papers), Prostate Cancer Treatment and Research (7 papers) and Sarcoma Diagnosis and Treatment (4 papers). Cyril Foa collaborates with scholars based in France, Belgium and Monaco. Cyril Foa's co-authors include M. Schneider, René‐Jean Bensadoun, Florence Pédeutour, Pierre‐Yves Marcy, F Démard, Nicolas Magné, M.-N. Falewee, Jean-­Marc Ferrero, G. Milano and N. Renée and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Cyril Foa

29 papers receiving 439 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cyril Foa France 12 181 181 80 74 67 31 457
Zhi‐Qing Long China 12 80 0.4× 237 1.3× 70 0.9× 128 1.7× 104 1.6× 30 483
Takatoshi Fujishita Japan 13 370 2.0× 554 3.1× 103 1.3× 103 1.4× 99 1.5× 32 793
Kensuke Kudou Japan 12 235 1.3× 202 1.1× 289 3.6× 80 1.1× 104 1.6× 36 577
Anne-Birgitte Jacobsen Norway 13 141 0.8× 184 1.0× 196 2.5× 84 1.1× 45 0.7× 30 452
Reza Rahbari United States 11 67 0.4× 167 0.9× 191 2.4× 147 2.0× 210 3.1× 16 780
Atsushi Takeno Japan 17 539 3.0× 271 1.5× 471 5.9× 80 1.1× 189 2.8× 137 945
Koujiro Nishida Japan 10 172 1.0× 144 0.8× 183 2.3× 63 0.9× 97 1.4× 15 395
Zhen-gang Xu China 16 136 0.8× 152 0.8× 478 6.0× 52 0.7× 76 1.1× 116 809
Christopher A. Peters United States 10 180 1.0× 132 0.7× 88 1.1× 161 2.2× 71 1.1× 25 467
Beatriz Cirauqui Spain 13 197 1.1× 357 2.0× 71 0.9× 168 2.3× 108 1.6× 56 549

Countries citing papers authored by Cyril Foa

Since Specialization
Citations

This map shows the geographic impact of Cyril Foa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cyril Foa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cyril Foa more than expected).

Fields of papers citing papers by Cyril Foa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cyril Foa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cyril Foa. The network helps show where Cyril Foa may publish in the future.

Co-authorship network of co-authors of Cyril Foa

This figure shows the co-authorship network connecting the top 25 collaborators of Cyril Foa. A scholar is included among the top collaborators of Cyril Foa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cyril Foa. Cyril Foa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Léary, Alexandra, Isabelle Laure Ray-Coquard, Bernard Asselain, et al.. (2023). LBA42 Olaparib vs placebo as maintenance therapy after platinum-based chemotherapy in advanced/metastatic endometrial cancer patients: The GINECO randomized phase IIb UTOLA trial. Annals of Oncology. 34. S1283–S1284. 11 indexed citations
2.
Joly, Florence, Dominique Vaur, Bernard Asselain, et al.. (2022). 2022-RA-922-ESGO Histo-molecular characteristics of platinum-sensitive advanced endometrial cancer: data issued from the population included in the GINECO UTOLA study. International Journal of Gynecological Cancer. 32. A118–A119.
3.
Barlési, Fabrice, Laurent Greillier, F. Monville, et al.. (2020). LBA53 Precision immuno-oncology for advanced non-small cell lung cancer (NSCLC) patients (pts) treated with PD1/L1 immune checkpoint inhibitors (ICIs): A first analysis of the PIONeeR study. Annals of Oncology. 31. S1183–S1183. 9 indexed citations
4.
Rouzier, Roman, David Gentien, Marie‐Ange Mouret‐Reynier, et al.. (2016). Prospective multicenter study of the impact of the Prosigna assay on adjuvant clinical decision-making in women with early stage breast cancer: which patients are the best candidates?. Journal of Clinical Oncology. 34(15_suppl). 543–543. 2 indexed citations
5.
Italiano, Antoîne, Georges Maire, Nicolas Sirvent, et al.. (2008). Variability of origin for the neocentromeric sequences in analphoid supernumerary marker chromosomes of well-differentiated liposarcomas. Cancer Letters. 273(2). 323–330. 19 indexed citations
6.
Chamorey, Emmanuel, et al.. (2006). Phase II trial evaluating a docetaxel‐capecitabine combination as treatment for hormone‐refractory prostate cancer. Cancer. 107(4). 738–745. 28 indexed citations
7.
Largillier, Rémy, Marie-Christine Étienne-Grimaldi, Jean–Louis Formento, et al.. (2006). Pharmacogenetics of Capecitabine in Advanced Breast Cancer Patients. Clinical Cancer Research. 12(18). 5496–5502. 78 indexed citations
8.
Magné, Nicolas, Cyril Foa, Pierre Castadot, et al.. (2006). [Guillain-Barré syndrome and non-Hodgkin's lymphoma. Report of one case and review of literature].. PubMed. 26(2). 108–11. 6 indexed citations
9.
Bondiau, Pierre‐Yves, Grégoire Malandain, S. Chanalet, et al.. (2004). Traitement des images et radiothérapie. Cancer/Radiothérapie. 8(2). 120–129. 2 indexed citations
10.
Ferrero, Jean-­Marc, Cyril Foa, Simon Thézenas, et al.. (2004). A Weekly Schedule of Docetaxel for Metastatic Hormone-Refractory Prostate Cancer. Oncology. 66(4). 281–287. 28 indexed citations
11.
Ferrero, Jean-­Marc, Nicolas Magné, Cyril Foa, Rémy Largillier, & Moïse Namer. (2003). Tolérance cardiaque des associations paclitaxel-anthracyclines dans le cadre de la prise en charge du cancer du sein. Bulletin du Cancer. 90(3). 219–226. 3 indexed citations
12.
Maire, Georges, Anne Forus, Cyril Foa, et al.. (2003). 11q13 Alterations in two cases of hibernoma: Large heterozygous deletions and rearrangement breakpoints near GARP in 11q13.5. Genes Chromosomes and Cancer. 37(4). 389–395. 33 indexed citations
13.
Bondiau, Pierre‐Yves, et al.. (2003). Traitement des métastases cérébrales du cancer de l’ovaire. Cancer/Radiothérapie. 7(3). 184–186. 2 indexed citations
14.
Foa, Cyril, C Mainguené, Florence Dupré, et al.. (2002). Rearrangement involving chromosomes 1 and 8 in a retroperitoneal lipoma. Cancer Genetics and Cytogenetics. 133(2). 156–159. 22 indexed citations
15.
Magné, Nicolas, Cyril Foa, Jean-Noël Bruneton, & Pierre‐Yves Marcy. (2001). Séminome du testicule et ostéonécrose aseptique multifocale au décours d’une chimiothérapie. La Revue de Médecine Interne. 22(1). 62–64. 4 indexed citations
16.
Magné, Nicolas, Pierre‐Yves Marcy, Cyril Foa, et al.. (2001). Comparison between nasogastric tube feeding and percutaneous fluoroscopic gastrostomy in advanced head and neck cancer patients. European Archives of Oto-Rhino-Laryngology. 258(2). 89–92. 83 indexed citations
17.
Pivot, Xavier, Clet Niyikiza, G. Poissonnet, et al.. (2001). Clinical Prognostic Factors for Patients with Recurrent Head and Neck Cancer: Implications for Randomized Trials. Oncology. 61(3). 197–204. 27 indexed citations
18.
Magné, Nicolas, Xavier Pivot, X. Tchiknavorian, et al.. (2001). Primary lung sarcomas: long survivors obtained with iterative complete surgery. Lung Cancer. 31(2-3). 241–245. 10 indexed citations
19.
Chevallier, P., et al.. (2000). Sonographic discovery of a pharyngocele. Journal of Clinical Ultrasound. 28(2). 101–103. 11 indexed citations
20.
Pivot, Xavier, Emmanuel Guardiola, M C Etienne, et al.. (2000). An analysis of potential factors allowing an individual prediction of cisplatin-induced anaemia. European Journal of Cancer. 36(7). 852–857. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhi‐Qing Long Breakdown of academic impact, for papers by Takatoshi Fujishita Breakdown of academic impact, for papers by Kensuke Kudou Breakdown of academic impact, for papers by Anne-Birgitte Jacobsen Breakdown of academic impact, for papers by Reza Rahbari Breakdown of academic impact, for papers by Atsushi Takeno Breakdown of academic impact, for papers by Koujiro Nishida Breakdown of academic impact, for papers by Zhen-gang Xu Breakdown of academic impact, for papers by Christopher A. Peters Breakdown of academic impact, for papers by Beatriz Cirauqui
Rankless by CCL
2026